{
    "ATR signaling pathway": "8991cbac-618b-11e5-8ac5-06603eb7f303", 
    "a4b7 Integrin signaling": "6e798e11-6186-11e5-8ac5-06603eb7f303", 
    "IL5-mediated signaling events": "e1d816a1-6193-11e5-8ac5-06603eb7f303", 
    "Canonical NF-kappaB pathway": "7a1a9c3c-618f-11e5-8ac5-06603eb7f303", 
    "E2F transcription factor network": "bb4d0fd3-6191-11e5-8ac5-06603eb7f303", 
    "p53 pathway": "a0de862d-6194-11e5-8ac5-06603eb7f303", 
    "Validated transcriptional targets of AP1 family members Fra1 and Fra2": "76d028a7-6196-11e5-8ac5-06603eb7f303", 
    "Beta5 beta6 beta7 and beta8 integrin cell surface interactions": "108637d6-618e-11e5-8ac5-06603eb7f303", 
    "Integrin family cell surface interactions": "1ca2bf67-6194-11e5-8ac5-06603eb7f303", 
    "Posttranslational regulation of adherens junction stability and dissassembly": "ebb21a59-6194-11e5-8ac5-06603eb7f303", 
    "S1P4 pathway": "821b0c12-6195-11e5-8ac5-06603eb7f303", 
    "Internalization of ErbB1": "3aa9aafa-6194-11e5-8ac5-06603eb7f303", 
    "PDGF receptor signaling network": "c5bcd922-6194-11e5-8ac5-06603eb7f303", 
    "RhoA signaling pathway": "5c6b5f5c-6195-11e5-8ac5-06603eb7f303", 
    "Class I PI3K signaling events mediated by Akt": "046a84e6-6191-11e5-8ac5-06603eb7f303", 
    "Aurora A signaling": "f131cf8e-618b-11e5-8ac5-06603eb7f303", 
    "Signaling events mediated by PRL": "bb67523a-6195-11e5-8ac5-06603eb7f303", 
    "S1P3 pathway": "7cb02d01-6195-11e5-8ac5-06603eb7f303", 
    "Visual signal transduction Rods": "962c6b0e-6196-11e5-8ac5-06603eb7f303", 
    "Endothelins": "dfb9dc47-6191-11e5-8ac5-06603eb7f303", 
    "Beta2 integrin cell surface interactions": "95b6b434-618d-11e5-8ac5-06603eb7f303", 
    "Integrins in angiogenesis": "2ddeac89-6194-11e5-8ac5-06603eb7f303", 
    "Ephrin A reverse signaling": "134e5bdb-6192-11e5-8ac5-06603eb7f303", 
    "FoxO family signaling": "d06dbbda-6192-11e5-8ac5-06603eb7f303", 
    "LPA receptor mediated events": "4b994cde-6194-11e5-8ac5-06603eb7f303", 
    "Alternative NF-kappaB pathway": "557add8c-6188-11e5-8ac5-06603eb7f303", 
    "E-cadherin signaling in the nascent adherens junction": "aef0d8c2-6191-11e5-8ac5-06603eb7f303", 
    "IL12-mediated signaling events": "7acdea19-6193-11e5-8ac5-06603eb7f303", 
    "IL6-mediated signaling events": "e684d5d2-6193-11e5-8ac5-06603eb7f303", 
    "Signaling events mediated by focal adhesion kinase": "8fb80085-6195-11e5-8ac5-06603eb7f303", 
    "Caspase Cascade in Apoptosis": "b9d3ef2e-618f-11e5-8ac5-06603eb7f303", 
    "Regulation of RhoA activity": "49ece019-6195-11e5-8ac5-06603eb7f303", 
    "EPHA2 forward signaling": "fb172ba9-6191-11e5-8ac5-06603eb7f303", 
    "Nectin adhesion pathway": "685baa82-6194-11e5-8ac5-06603eb7f303", 
    "Regulation of RAC1 activity": "351aacd6-6195-11e5-8ac5-06603eb7f303", 
    "Syndecan-4-mediated signaling events": "076bc549-6196-11e5-8ac5-06603eb7f303", 
    "VEGFR3 signaling in lymphatic endothelium": "9048d98c-6196-11e5-8ac5-06603eb7f303", 
    "Regulation of CDC42 activity": "0ffe6681-6195-11e5-8ac5-06603eb7f303", 
    "Validated nuclear estrogen receptor alpha network": "58949883-6196-11e5-8ac5-06603eb7f303", 
    "IL4-mediated signaling events": "cff33f50-6193-11e5-8ac5-06603eb7f303", 
    "Class I PI3K signaling events": "12b82bb7-6191-11e5-8ac5-06603eb7f303", 
    "Calcineurin-regulated NFAT-dependent transcription in lymphocytes": "0439e9da-618f-11e5-8ac5-06603eb7f303", 
    "Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling": "503076a2-6196-11e5-8ac5-06603eb7f303", 
    "ErbB receptor signaling network": "2c26d51f-6192-11e5-8ac5-06603eb7f303", 
    "Regulation of nuclear SMAD23 signaling": "246aac04-6195-11e5-8ac5-06603eb7f303", 
    "PLK1 signaling events": "e5e87977-6194-11e5-8ac5-06603eb7f303", 
    "PDGFR-beta signaling pathway": "c901a3e4-6194-11e5-8ac5-06603eb7f303", 
    "Validated nuclear estrogen receptor beta network": "5fb983a4-6196-11e5-8ac5-06603eb7f303", 
    "Stabilization and expansion of the E-cadherin adherens junction": "f1a6cd94-6195-11e5-8ac5-06603eb7f303", 
    "Fanconi anemia pathway": "6befb873-6192-11e5-8ac5-06603eb7f303", 
    "Presenilin action in Notch and Wnt signaling": "f51de83a-6194-11e5-8ac5-06603eb7f303", 
    "ErbB2ErbB3 signaling events": "51e35311-6192-11e5-8ac5-06603eb7f303", 
    "Sphingosine 1-phosphate (S1P) pathway": "eff796f3-6195-11e5-8ac5-06603eb7f303", 
    "Hedgehog signaling events mediated by Gli proteins": "153b6970-6193-11e5-8ac5-06603eb7f303", 
    "Signaling events mediated by PTP1B": "be498a9b-6195-11e5-8ac5-06603eb7f303", 
    "BARD1 signaling events": "75b04491-618c-11e5-8ac5-06603eb7f303", 
    "IL23-mediated signaling events": "b71d0ffd-6193-11e5-8ac5-06603eb7f303", 
    "Trk receptor signaling mediated by PI3K and PLC-gamma": "4037def0-6196-11e5-8ac5-06603eb7f303", 
    "CDC42 signaling events": "50b98ae0-6190-11e5-8ac5-06603eb7f303", 
    "IL1-mediated signaling events": "68fce8e7-6193-11e5-8ac5-06603eb7f303", 
    "Endogenous TLR signaling": "d8777e16-6191-11e5-8ac5-06603eb7f303", 
    "Signaling events mediated by VEGFR1 and VEGFR2": "d6f6ae1f-6195-11e5-8ac5-06603eb7f303", 
    "BCR signaling pathway": "acbf44e2-618c-11e5-8ac5-06603eb7f303", 
    "Regulation of p38-alpha and p38-beta": "3062ca15-6195-11e5-8ac5-06603eb7f303", 
    "Plexin-D1 Signaling": "e3068f36-6194-11e5-8ac5-06603eb7f303", 
    "Signaling events mediated by HDAC Class II": "a1da5607-6195-11e5-8ac5-06603eb7f303", 
    "a6b1 and a6b4 Integrin signaling": "73d1a893-6186-11e5-8ac5-06603eb7f303", 
    "Wnt signaling network": "987a2b9f-6196-11e5-8ac5-06603eb7f303", 
    "Arf6 downstream pathway": "1e972087-618a-11e5-8ac5-06603eb7f303", 
    "Insulin Pathway": "073b9f25-6194-11e5-8ac5-06603eb7f303", 
    "Signaling mediated by p38-gamma and p38-delta": "eef25bf2-6195-11e5-8ac5-06603eb7f303", 
    "LPA4-mediated signaling events": "53b0602f-6194-11e5-8ac5-06603eb7f303", 
    "Validated targets of C-MYC transcriptional repression": "6bbdafa6-6196-11e5-8ac5-06603eb7f303", 
    "ATF-2 transcription factor network": "c76c900a-618a-11e5-8ac5-06603eb7f303", 
    "Signaling events mediated by Stem cell factor receptor (c-Kit)": "c6b6861c-6195-11e5-8ac5-06603eb7f303", 
    "Alpha6 beta4 integrin-ligand interactions": "01416eb3-6188-11e5-8ac5-06603eb7f303", 
    "CXCR3-mediated signaling events": "3a38a0ca-6191-11e5-8ac5-06603eb7f303", 
    "Notch-mediated HESHEY network": "8ee56389-6194-11e5-8ac5-06603eb7f303", 
    "Calcium signaling in the CD4 TCR pathway": "5294f70b-618f-11e5-8ac5-06603eb7f303", 
    "Ephrin B reverse signaling": "149a63dc-6192-11e5-8ac5-06603eb7f303", 
    "PDGFR-alpha signaling pathway": "c66cc833-6194-11e5-8ac5-06603eb7f303", 
    "VEGFR1 specific signals": "8b13143b-6196-11e5-8ac5-06603eb7f303", 
    "IL12 signaling mediated by STAT4": "72cf19b8-6193-11e5-8ac5-06603eb7f303", 
    "ALK1 signaling events": "fcc72679-6186-11e5-8ac5-06603eb7f303", 
    "S1P2 pathway": "7796a240-6195-11e5-8ac5-06603eb7f303", 
    "RXR and RAR heterodimerization with other nuclear receptor": "6ce0a11e-6195-11e5-8ac5-06603eb7f303", 
    "AP-1 transcription factor network": "3ce2f9c5-6189-11e5-8ac5-06603eb7f303", 
    "Regulation of nuclear beta catenin signaling and target gene transcription": "1590a3b3-6195-11e5-8ac5-06603eb7f303", 
    "FAS (CD95) signaling pathway": "79cc9c14-6192-11e5-8ac5-06603eb7f303", 
    "ErbB4 signaling events": "6104ebb2-6192-11e5-8ac5-06603eb7f303", 
    "Arf6 signaling events": "3b3d91b8-618a-11e5-8ac5-06603eb7f303", 
    "Reelin signaling pathway": "054f432f-6195-11e5-8ac5-06603eb7f303", 
    "Alpha-synuclein signaling": "588134bc-6187-11e5-8ac5-06603eb7f303", 
    "IFN-gamma pathway": "51b1ed75-6193-11e5-8ac5-06603eb7f303", 
    "Signaling events mediated by HDAC Class I": "97e84126-6195-11e5-8ac5-06603eb7f303", 
    "PLK3 signaling events": "eac8a4b8-6194-11e5-8ac5-06603eb7f303", 
    "C-MYC pathway": "e3162de9-618e-11e5-8ac5-06603eb7f303", 
    "IL27-mediated signaling events": "c134fc5e-6193-11e5-8ac5-06603eb7f303", 
    "Regulation of Ras family activation": "397d91c7-6195-11e5-8ac5-06603eb7f303", 
    "Neurotrophic factor-mediated Trk receptor signaling": "774988f5-6194-11e5-8ac5-06603eb7f303", 
    "Validated transcriptional targets of TAp63 isoforms": "82e8ee19-6196-11e5-8ac5-06603eb7f303", 
    "IL8- and CXCR1-mediated signaling events": "f6a58ef3-6193-11e5-8ac5-06603eb7f303", 
    "mTOR signaling pathway": "559dd850-6194-11e5-8ac5-06603eb7f303", 
    "p75(NTR)-mediated signaling": "b492782f-6194-11e5-8ac5-06603eb7f303", 
    "Alpha4 beta1 integrin signaling events": "aa07df5d-6187-11e5-8ac5-06603eb7f303", 
    "Class IB PI3K non-lipid kinase events": "263703f8-6191-11e5-8ac5-06603eb7f303", 
    "Angiopoietin receptor Tie2-mediated signaling": "ad60647c-6188-11e5-8ac5-06603eb7f303", 
    "Signaling events mediated by HDAC Class III": "a7191c08-6195-11e5-8ac5-06603eb7f303", 
    "S1P5 pathway": "845321c3-6195-11e5-8ac5-06603eb7f303", 
    "p38 MAPK signaling pathway": "99bea41b-6194-11e5-8ac5-06603eb7f303", 
    "SHP2 signaling": "85755aa4-6195-11e5-8ac5-06603eb7f303", 
    "Ceramide signaling pathway": "d3747df2-6190-11e5-8ac5-06603eb7f303", 
    "Cellular roles of Anthrax toxin": "bb877621-6190-11e5-8ac5-06603eb7f303", 
    "Regulation of Telomerase": "4dfe97ca-6195-11e5-8ac5-06603eb7f303", 
    "IL2-mediated signaling events": "a2a1883c-6193-11e5-8ac5-06603eb7f303", 
    "Glucocorticoid receptor regulatory network": "dfba0dfb-6192-11e5-8ac5-06603eb7f303", 
    "Glypican 3 network": "07762c7e-6193-11e5-8ac5-06603eb7f303", 
    "PAR1-mediated thrombin signaling events": "be5084c0-6194-11e5-8ac5-06603eb7f303", 
    "Sumoylation by RanBP2 regulates transcriptional repression": "f70a59a5-6195-11e5-8ac5-06603eb7f303", 
    "BMP receptor signaling": "2a3c66e7-618e-11e5-8ac5-06603eb7f303", 
    "Glypican 2 network": "0723edcd-6193-11e5-8ac5-06603eb7f303", 
    "CD40CD40L signaling": "1971792f-6190-11e5-8ac5-06603eb7f303", 
    "Noncanonical Wnt signaling pathway": "7ff5fe76-6194-11e5-8ac5-06603eb7f303", 
    "p38 signaling mediated by MAPKAP kinases": "9d980dbc-6194-11e5-8ac5-06603eb7f303", 
    "Degradation of beta catenin": "61b6f2fc-6191-11e5-8ac5-06603eb7f303", 
    "IL2 signaling events mediated by STAT5": "9938526b-6193-11e5-8ac5-06603eb7f303", 
    "Role of Calcineurin-dependent NFAT signaling in lymphocytes": "61bdd46d-6195-11e5-8ac5-06603eb7f303", 
    "Circadian rhythm pathway": "ffb11b85-6190-11e5-8ac5-06603eb7f303", 
    "Ras signaling in the CD4 TCR pathway": "03079d1e-6195-11e5-8ac5-06603eb7f303", 
    "Signaling events mediated by the Hedgehog family": "d3a49cee-6195-11e5-8ac5-06603eb7f303", 
    "Syndecan-2-mediated signaling events": "fe05ead7-6195-11e5-8ac5-06603eb7f303", 
    "PAR4-mediated thrombin signaling events": "c3b87da1-6194-11e5-8ac5-06603eb7f303", 
    "Insulin-mediated glucose transport": "145e3376-6194-11e5-8ac5-06603eb7f303", 
    "HIF-2-alpha transcription factor network": "37358832-6193-11e5-8ac5-06603eb7f303", 
    "amb2 Integrin signaling": "5d4f90b6-6188-11e5-8ac5-06603eb7f303", 
    "ErbB1 downstream signaling": "30d60550-6192-11e5-8ac5-06603eb7f303", 
    "Beta1 integrin cell surface interactions": "2fd0bc63-618d-11e5-8ac5-06603eb7f303", 
    "p73 transcription factor network": "a88c505e-6194-11e5-8ac5-06603eb7f303", 
    "Beta3 integrin cell surface interactions": "c2800165-618d-11e5-8ac5-06603eb7f303", 
    "EPHA forward signaling": "f25420e8-6191-11e5-8ac5-06603eb7f303", 
    "Regulation of retinoblastoma protein": "407a3468-6195-11e5-8ac5-06603eb7f303", 
    "Nongenotropic Androgen signaling": "843e2f77-6194-11e5-8ac5-06603eb7f303", 
    "Direct p53 effectors": "67c3b75d-6191-11e5-8ac5-06603eb7f303", 
    "Arf6 trafficking events": "7a5b8f09-618a-11e5-8ac5-06603eb7f303", 
    "FOXA1 transcription factor network": "aa3927b7-6192-11e5-8ac5-06603eb7f303", 
    "HIV-1 Nef Negative effector of Fas and TNF-alpha": "41a75463-6193-11e5-8ac5-06603eb7f303", 
    "Plasma membrane estrogen receptor signaling": "dcc37895-6194-11e5-8ac5-06603eb7f303", 
    "Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)": "ac39d2b9-6195-11e5-8ac5-06603eb7f303", 
    "S1P1 pathway": "7327884f-6195-11e5-8ac5-06603eb7f303", 
    "Trk receptor signaling mediated by the MAPK pathway": "4980bb81-6196-11e5-8ac5-06603eb7f303", 
    "IL2 signaling events mediated by PI3K": "8bbf39aa-6193-11e5-8ac5-06603eb7f303", 
    "Netrin-mediated signaling events": "716a3d34-6194-11e5-8ac5-06603eb7f303", 
    "EGF receptor (ErbB1) signaling pathway": "a3139206-c718-11e6-86b1-0ac135e8bacf", 
    "Fc-epsilon receptor I signaling in mast cells": "86cd7795-6192-11e5-8ac5-06603eb7f303", 
    "Regulation of Androgen receptor activity": "094a8cb0-6195-11e5-8ac5-06603eb7f303", 
    "VEGF and VEGFR signaling network": "8957818a-6196-11e5-8ac5-06603eb7f303", 
    "C-MYB transcription factor network": "61020228-618e-11e5-8ac5-06603eb7f303", 
    "IL8- and CXCR2-mediated signaling events": "fe78e284-6193-11e5-8ac5-06603eb7f303", 
    "Alpha9 beta1 integrin signaling events": "0f5519cf-6188-11e5-8ac5-06603eb7f303", 
    "Syndecan-1-mediated signaling events": "f957cc16-6195-11e5-8ac5-06603eb7f303", 
    "N-cadherin signaling events": "5fc9c1e1-6194-11e5-8ac5-06603eb7f303", 
    "Validated targets of C-MYC transcriptional activation": "61d3b115-6196-11e5-8ac5-06603eb7f303", 
    "EPO signaling pathway": "20fe3c0e-6192-11e5-8ac5-06603eb7f303", 
    "Atypical NF-kappaB pathway": "d2dd121d-618b-11e5-8ac5-06603eb7f303", 
    "CXCR4-mediated signaling events": "46a5529b-6191-11e5-8ac5-06603eb7f303", 
    "Aurora C signaling": "72a32ba0-618c-11e5-8ac5-06603eb7f303", 
    "JNK signaling in the CD4 TCR pathway": "400ebdab-6194-11e5-8ac5-06603eb7f303", 
    "Visual signal transduction Cones": "9433a84d-6196-11e5-8ac5-06603eb7f303", 
    "HIF-1-alpha transcription factor network": "20ef2b81-6193-11e5-8ac5-06603eb7f303", 
    "Aurora B signaling": "304a75af-618c-11e5-8ac5-06603eb7f303", 
    "FOXA2 and FOXA3 transcription factor networks": "b6933be8-6192-11e5-8ac5-06603eb7f303", 
    "TRAIL signaling pathway": "3a79fddf-6196-11e5-8ac5-06603eb7f303", 
    "Rapid glucocorticoid signaling": "01db03fd-6195-11e5-8ac5-06603eb7f303", 
    "TNF receptor signaling pathway ": "316be05e-6196-11e5-8ac5-06603eb7f303", 
    "EPHB forward signaling": "01c81f4a-6192-11e5-8ac5-06603eb7f303", 
    "GMCSF-mediated signaling events": "095aa3ef-6193-11e5-8ac5-06603eb7f303", 
    "Integrin-linked kinase signaling": "21738158-6194-11e5-8ac5-06603eb7f303", 
    "DNA-PK pathway in nonhomologous end joining": "8dc10ede-6191-11e5-8ac5-06603eb7f303", 
    "FOXM1 transcription factor network": "c51cda49-6192-11e5-8ac5-06603eb7f303", 
    "EGFR-dependent Endothelin signaling events": "d4563605-6191-11e5-8ac5-06603eb7f303", 
    "Signaling events regulated by Ret tyrosine kinase": "e4431190-6195-11e5-8ac5-06603eb7f303", 
    "Syndecan-3-mediated signaling events": "052075b8-6196-11e5-8ac5-06603eb7f303", 
    "FGF signaling pathway": "98ed0df6-6192-11e5-8ac5-06603eb7f303", 
    "Osteopontin-mediated events": "94bf7f2a-6194-11e5-8ac5-06603eb7f303", 
    "Coregulation of Androgen receptor activity": "27e0e369-6191-11e5-8ac5-06603eb7f303", 
    "Signaling events mediated by TCPTP": "cd5ca44d-6195-11e5-8ac5-06603eb7f303", 
    "Regulation of cytoplasmic and nuclear SMAD23 signaling": "13312fe2-6195-11e5-8ac5-06603eb7f303", 
    "IGF1 pathway": "5e904cd6-6193-11e5-8ac5-06603eb7f303", 
    "RAC1 signaling pathway": "faffa4fc-6194-11e5-8ac5-06603eb7f303", 
    "NephrinNeph1 signaling in the kidney podocyte": "6cfb9873-6194-11e5-8ac5-06603eb7f303", 
    "Arf1 pathway": "faef51c6-6189-11e5-8ac5-06603eb7f303", 
    "ALK2 signaling events": "43d0451b-6187-11e5-8ac5-06603eb7f303", 
    "Retinoic acid receptors-mediated signaling": "5797691b-6195-11e5-8ac5-06603eb7f303", 
    "Effects of Botulinum toxin": "d236ff84-6191-11e5-8ac5-06603eb7f303", 
    "Notch signaling pathway": "88f83518-6194-11e5-8ac5-06603eb7f303", 
    "TGF-beta receptor signaling": "1f188fcc-6196-11e5-8ac5-06603eb7f303", 
    "IL3-mediated signaling events": "c868db9f-6193-11e5-8ac5-06603eb7f303", 
    "ATM pathway": "49bc3e2b-618b-11e5-8ac5-06603eb7f303", 
    "Canonical Wnt signaling pathway": "9dbe253d-618f-11e5-8ac5-06603eb7f303", 
    "Thromboxane A2 receptor signaling": "27d5800d-6196-11e5-8ac5-06603eb7f303", 
    "Hypoxic and oxygen homeostasis regulation of HIF-1-alpha": "4c0f3584-6193-11e5-8ac5-06603eb7f303", 
    "Glypican 1 network": "fb91e48c-6192-11e5-8ac5-06603eb7f303", 
    "E-cadherin signaling in keratinocytes": "a5f1af61-6191-11e5-8ac5-06603eb7f303", 
    "Lissencephaly gene (LIS1) in neuronal migration and development": "41fc83ec-6194-11e5-8ac5-06603eb7f303", 
    "Signaling mediated by p38-alpha and p38-beta": "e9dd8c21-6195-11e5-8ac5-06603eb7f303", 
    "Validated transcriptional targets of deltaNp63 isoforms": "7d7360a8-6196-11e5-8ac5-06603eb7f303", 
    "LKB1 signaling events": "4623bf6d-6194-11e5-8ac5-06603eb7f303"
}